Pharmaceutical Business review

Access Pharmaceuticals names new CEO

Stephen Seiler has resigned as president and CEO of the company for health reasons. Mr. Seiler has also resigned from the board of directors.

Mr. Davis said: “I am excited about Access’s prospects in 2008 and beyond and look forward to working with the organization to build on recent achievements.”